Markets › Stocks › DRLAL
DR

Dr Lal PathLabs

NSE: DRLALHealthcare
₹1,562.80
▼ -0.40%
NSE · 15-min delayed
Mkt Cap
₹28,000 Cr
P / E
56.0
P / B
8.4
ROE
20.3%
52W High
₹1,771.30
52W Low
₹1,272.00
Key Metrics
Market Cap
₹28,000 Cr
P / E
56.0
P / B
8.4
ROCE
27.6%
ROE
20.3%
Div Yield
0.6%
Revenue · ₹ Cr
1.3k
FY20
1.6k
FY21
2.1k
FY22
2.0k
FY23
2.2k
FY24
2.5k
FY25
2.8k
FY26
Net Profit · ₹ Cr
228
FY20
297
FY21
350
FY22
241
FY23
362
FY24
492
FY25
510
FY26
EPS · ₹ per share
₹27.4
FY20
₹35.3
FY21
₹41.7
FY22
₹28.8
FY23
₹43.0
FY24
₹58.5
FY25
₹30.2
FY26
Q1 2026 snapshot
Sales
₹727 Cr
Operating profit
-
OPM
-
Net profit
₹132 Cr
EPS
₹7.86
Scorecard · 7 axes
Quality
Strong
85/100
Valuation
Weak
56.0×
Growth
Avg
+8.5%
Profitability
Strong
24.0%
Performance
Avg
+10.7%
Entry Point
Avg
88%
Red Flags
Strong
0 flags
Shareholding Pattern
53.2%Promoter
Promoter53.2%
FII17.2%
DII21.4%
Public8.2%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue621.8628.4697.9755.4684.2726.7
Net Profit98.1155.5134152.291.4132.2
NPM %15.8%24.7%19.2%20.1%13.4%18.2%
AlertPre-trade